GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » BioAdaptives Inc (OTCPK:BDPT) » Definitions » Future 3-5Y EPS without NRI Growth Rate

BDPT (BioAdaptives) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Jul. 24, 2025)


View and export this data going back to 2014. Start your Free Trial

What is BioAdaptives Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, BioAdaptives's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of BioAdaptives's Future 3-5Y EPS without NRI Growth Rate

For the Packaged Foods subindustry, BioAdaptives's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioAdaptives's Future 3-5Y EPS without NRI Growth Rate Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioAdaptives's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where BioAdaptives's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

BioAdaptives  (OTCPK:BDPT) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


BioAdaptives Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of BioAdaptives's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


BioAdaptives Business Description

Traded in Other Exchanges
N/A
Address
2620 Regatta Drive, Suite 102, Las Vegas, NV, USA, 89128
BioAdaptives Inc is engaged in investigating, marketing and distributing natural plant- and algal-based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. The Company's current products in development include a weight management supplement in a Human Clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara, PawPa, and MyndMed are also some of its products.
Executives
Richard Chiang other: Previous Officer and Director 460 BRANNAN STREET SUITE 78064, SAN FRANCISCO CA 94107
Barry Epling director 2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128
Ferris Holding Inc. 10 percent owner 2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128
Gerald Epling director, officer: Pres, CEO, Secretary, CFO 2251 NORTH RAMPART BLVD., #182, LAS VEGAS NV 89128

BioAdaptives Headlines

From GuruFocus

BioAdaptives Sponsors COVID-19 Long Hauler Survey

By PurpleRose PurpleRose 07-12-2022

BioAdaptives Sponsors COVID-19 Long Hauler Survey

By GuruFocusNews GuruFocusNews 07-02-2022